Transaction · 0001628280-26-019010

Davis George Eric

Davis George Eric, EVP, CLO, reported a transaction classified as withholding at BIOMARIN PHARMACEUTICAL INC involving 7177.000000 shares for an estimated $419926.27. Reported holdings after the transaction were 65263.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, CLO
BMRNBIOMARIN PHARMACEUTICAL INC
Filing timeMar 17
Trade dateMar 16, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$56.05
Pre-filing
1mo ago +6.8%1w ago +8.6%1d ago +4.4%
Returns since
7d -3.5%30d -3.5%90d -0.7%180d +18.0%1y +18.0%

BMRN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BMRN since 2026-03-17Filed 171 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001628280-26-019010
Common Stock
Transaction date
Mar 16, 2026
Filed Mar 17, 2026, 12:00 AM · 1d delay
Shares
7.17k sh
$5.85k per share
Estimated value
-$41.9M
Computed from shares × price
Holdings after
65.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Restricted stock units granted March 16, 2026. Price not applicable.

  2. F2

    The Reporting Person's direct holdings have been adjusted by thirteen shares to correct a previous clerical error.

  3. F3

    Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.

Original filing · 0001628280-26-019010
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BMRN